Teva’s generic Narcan nasal spray to treat opioid overdose is the first to arrive on the US market, the company says.

Israeli pharmaceutical giant Teva has announced the launch of the first available generic version of a nasal spray used to treat opioid overdose.

Naloxone hydrochloride nasal spray, currently sold under the brand name Narcan, is used in emergencies to block the effects of opioid drugs.

The US has in recent years faced a crisis over opioid drug addiction, which has caused more than 500,000 overdose deaths in the country over the past 20 years.

Get the full story at timesofisrael.com.


Teva Generic Narcan

Go To Source For Respiratory Therapy Coverage

RT delivers in-depth coverage of the clinical, regulatory, and technology landscape for respiratory therapy—and reaches more than 28,000 key decision-makers and influencers. As one of healthcare’s most important data companies, we facilitate the rapid adoption of medical devices and practice management tools into the industry.

Go To Source For Respiratory Therapy Coverage RT delivers in-depth coverage of the clinical, regulatory, and technology landscape for respiratory therapy—and reaches more than 28,000 key decision-makers and influencers. As one of healthcare’s most important data companies, we facilitate the rapid adoption of medical devices and practice management tools into the industry.